ImmuCell Corporation
ICCC
$5.25
$0.255.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -14.57% | -20.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -14.57% | -20.11% | |||
| Cost of Revenue | -13.34% | -23.05% | |||
| Gross Profit | -16.14% | -15.98% | |||
| SG&A Expenses | 16.39% | -4.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.63% | -15.46% | |||
| Operating Income | -96.47% | -49.03% | |||
| Income Before Tax | -126.86% | -65.23% | |||
| Income Tax Expenses | 136.84% | 0.00% | |||
| Earnings from Continuing Operations | -127.83% | -65.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -127.83% | -65.31% | |||
| EBIT | -96.47% | -49.03% | |||
| EBITDA | -43.51% | -30.99% | |||
| EPS Basic | -127.70% | -65.49% | |||
| Normalized Basic EPS | -114.53% | -51.89% | |||
| EPS Diluted | -135.97% | -65.25% | |||
| Normalized Diluted EPS | -114.53% | -51.89% | |||
| Average Basic Shares Outstanding | 0.16% | 0.56% | |||
| Average Diluted Shares Outstanding | 0.16% | 0.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||